SUMMARY Cell-mediated immunity in rheumatoid arthritis (RA) was assessed by skin testing with six antigens in 107 patients, 94 of whom were age, sex, and race-matched with healthy individuals or patients with diseases unrelated to immunological abnormalities. 20 % of RA patients were anergic. Impaired cell-mediated immunity in the RA patients was manifested by a decrease in the magnitude of skin reactivity as well as a decrease in the incidence of positive reactions to multiple antigens. Depression in cell-mediated immunity was related to age but not to sex, duration of disease, or dise4se activity. A slight correlation was found between absolute peripheral lymphocyte counts and the number of positive skin tests, and was confirmed by finding an association between lymphocyte counts and the size of skin reactions. A correlation was also found between lymphocyte counts and disease activity.
the number of positive skin tests, and was confirmed by finding an association between lymphocyte counts and the size of skin reactions. A correlation was also found between lymphocyte counts and disease activity.
Four explanations of the observed depression in cell-mediated immunity in RA were considered: (1) a preoccupation of the immune mechanism of the host with cell-mediated immunity reactions related to the pathogenesis of the disease; (2) a depression of cell-mediated immune reactivity by a virus infection; (3) depression of cell-mediated immunity by therapy; and (4) immune complex suppression of cell-mediated immunity. No effect of gold therapy was found. The near universal use of salicylates or other anti-inflammatory drugs did not permit investigation of the effect of these drugs on cell-mediated immunity.
Cell-mediated immune reactions may participate in the pathogenesis of rheumatoid arthritis (RA), although their precise role has not been elucidated. Several investigators have reported depressed skin reactivity to common antigens in RA patients (Wasz-H6ckert, 1951; Houba et al., 1964; Hayes et al., 1970; Bacon, 1970; Bitter, 1971; Waxman, et al., 1973; Toh et al., 1973) , and Epstein and Jessar (1959) have reported a decreased capacity for sensitization in these patients. A correlation between anergy and long duration of disease has been reported (Waxman et a!., 1973) , but whether there is any relation between skin reactivity and the course of the disease has not been determined. This study taking salicylates, indomethacin or paracetamol. Of48 patients not treated with gold, 42 were receiving only aspirin, indomethacin, or paracetamol. 6 patients were receiving prednisone in addition to anti-inflammatory drugs; 5 were on 5 mg/day and one was on 10 mg/day. 5 of the RA patients were seronegative and 2 had Felty's syndrome.
A history was taken and a physical examination was performed by the same physician on each patient at the time of skin testing. A complete blood count, Wintrobe erythrocyte sedimentation rate (ESR), anti-IgG titre, and serum protein electrophoresis were obtained in most patients at the same time. Absolute peripheral lymphocyte counts were calculated from the differential cell count and the total white blood cell count. The latex fixation test for anti-IgG activity was carried out on twofold serum dilutions of 1:40 through 1:81 920 using a technique described previously (Singer and Plotz, 1956) . Serum protein electrophoresis was done in the individual hospital laboratories. Pretreatment clinical and laboratory data were available on the patients receiving gold therapy from the records of another study. Disease activity was assessed by the articular index (Lansbury and Haut, 1956 Results were analysed comparing either the matched or the total patient groups to the control subjects and no differences were found. The data presented here are from the total patient group.
SKIN TESTING
All RA patients and controls received 01 ml intradermal injections of the following six antigens.
(1) Purified protein derivative (PPD) (Connaught, Lot 15021-1), 50 IU/ml; (2) mumps skin test antigen (Eli Lilly & Co., Lot DNC 2-V24-l); (3) streptokinase-streptodomase (SK-SD) (Varidase, Lederle, Lot 5-2201-66), 400 units of streptokinase and 100 units of streptodornase per ml; (4) dermatophytin 'O' (Hollister-Stier, Lot H50637 M), 1:100 dilution; (5) mixed monilia antigens (Hollister-Stier, Lot F4454710), 1: 100 dilution; (6) dermatophytin (Trichophytin) (Hollister-Stier, Lot E40098 M), 1:100 dilution.
The injections were made into the anterior surface of the forearms and skin reactions were read 48 hours later. Two perpendicular diameters of the induration were measured and the mean of these measurements was recorded. Induration with a mean diameter of 5 mm or more was considered a positive reaction for all antigens except PDD in which instance a mean diameter of 10 mm or more was considered positive (Shaffer and Goldin, 1969 (Hill, 1961 Cell-mediated immunity in rheumatoid arthritis 15 and 4 or more skin test antigens was found to be significantly higher among the control group than in RA patients (Fig. 1) .
The degree of skin reactivity as measured by induration was found to be significantly lower in RA patients than in the control group for four antigens: PPD, SK-SD, dermatophytin 'O', and mixed monilia antigens (Fig. 2) Several factors reflecting the severity and course of arthritis were examined (Table 5 ). These included the duration of the disease, articular index, incidence of subcutaneous nodules, age, ESR, anti-IgG titres, serum proteins, and absolute peripheral lymphocyte counts. None was significantly related to anergy. However, when the effect of age on induration of skin test responses among patients and controls reacting to a given antigen was examined, it was found that older individuals in both groups had smaller mean reactions for every antigen, although differences for specific antigens were significant in only three instances (Table 6 ).
An apparent relationship was found between anergy and inactive disease, defined as an articular index of 0 (Table 7) . Among the anergic patients 20 % had inactive disease while only 5 % of the reactive patients had inactive disease. This difference was largely accounted for by the anergic group on gold therapy, among whom 30 % had inactive disease. Although this difference is significant (P<0-01) it should be noted that the number of patients with inactive disease was small and a shift of one patient from the inactive, anergic group would change the P value from <0-01 to > 0 05. To test further the significance of this finding the incidence of positive skin reactions was examined for a relationship to disease activity as measured by articular index (Fig. 3) . Mumps, SK-SD, and any one of the other antigens were included in the three major antigens. The patients were divided into four equal groups with group I being the least active. The incidence of positive skin reactions in group III was lower than in all other groups, but the significance of this observation is doubtful since there was no scaling from group I through group IV.
The mean diameter of skin induration induced by SK-SD increased progressively from group I through III, but the differences were not significant (Fig. 4) . (Fig. 5) (Fig. 6 ).
EFFECT OF TREATMENT
The incidence of positive tests and the mean diameters of skin reactions in patients receiving gold salts were not different from the entire group in spite of striking differences in disease activity, lymphocyte counts, serum protein, and anti-IgG titres (Table 8) . Although the patients who were receiving gold were not matched or paired with the other patients with RA, the differences shown in Table 8 In each of the previous negative studies either the number of the patients studied was less than 25 (Block et a!., 1968; Curtis et al., 1973) or only one skin test antigen was used (Muller, 1971) (Thiele and Rothenberger, 1971; Bacon et al., 1973) . Nonrheumatoid synovial extracts failed to inhibit leucocyte migration (Bacon et al., 1973) .
In other studies aggregated IgG has been reported to inhibit leucocyte migration in RA patients, but not in control groups (Froland and Gaarder, 1973; Brostoff et al., 1973) , although it does not induce lymphocyte blastogenesis (Kacaki et al., 1969 (Wegelius et al., 1970) and also Cell-mediated immunity in rheumatoid arthritis 19 suppressed cell-mediated immunity as assessed by skin testing (Paulus et al., 1972) . Ziff has inferred that both T and B lymphocytes are present in the synovial tissue (Ziff, 1974) . T-cells are the predominant lymphocyte in rheumatoid synovial fluid . Finally, synovitis has been induced in rabbits by intra-articular injections of lymphokines (Ishikawa et al., 1973) , and recently lymphokine-like substances have been found in synovial fluid from RA patients (Stastny et al., 1975) . Other evidence for a role for cell-mediated immunity in RA is provided in this study by positive correlations between lymphocyte counts and disease activity and between lymphocyte counts and the number and magnitude of skin reactions.
Although at present there is no convincing evidence that RA is an infectious disease it should be noted that impaired cell-mediated immunity has been reported in a number of viral, bacterial, fungal, and parasitic infections (Salaman, 1969) .
The role of therapy was evaluated by examining subgroups of patients. Since the frequency of anergy was similar in patients treated with gold as compared with those not receiving gold, this medication would not appear to be a likely cause for the observed depression of delayed reactions. Recently aspirin and several other anti-inflammatory drugs have been reported to depress lymphocyte reactivity in vitro (Pachman et al., 1971; Opelz et al., 1973) . Since nearly all the patients in this study were receiving aspirin or indomethacin it was not possible to evaluate the role of these agents in the depressed cell-mediated immunity skin reactivity observed.
Neither the data from this study nor those published provide convincing evidence in favour of any of the possible explanations for depressed cellmediated immunity in RA, and additional studies will be required to ascertain the exact significance of this observation. rheumatoid arthritis. 
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